Latest Molecular neuroscience Stories
Jackson Laboratory researchers led by Associate Professor Zhong-wei Zhang, Ph.D., have provided direct evidence that a specific neurotransmitter receptor is vital to the process of pruning synapses in the brains of newborn mammals.
Alzheimer's disease is one of the most common causes of dementia.
Johns Hopkins researchers report the successful use of a form of MRI to identify what appears to be a key biochemical marker for cognitive impairment in the brains of people with multiple sclerosis (MS).
Scientists may have discovered why the standard treatment for Parkinson's disease is often effective for only a limited period of time.
A study by researchers at Washington University School of Medicine in St. Louis involving laboratory mice found that sleep disruption could be an early sign of Alzheimer’s disease.
Researchers have succeeded in tracking a single protein that regulates the neurotransmitter serotonin, making it possible to study the dynamics of the protein which regulates mood, appetite and sleep, at an unprecedented level of detail.
Early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder (ASD), and other "enduring effects on behavior," Vanderbilt University researchers report.
Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke.
Researchers have revealed that the neural circuits controlling hunger and eating behaviors are also controlled by plasticity.